Attendee Guidance

  • If you attended all day of CME lectures “live stream”, you are not required to complete the quiz.
  • If you partially attended, or missed lectures, in addition to completion of the on-line Evaluation Form, you are also required to complete the multiple-choice questions for ONLY those CME lectures that you missed, to be eligible for CME accreditation.
  • Once you have watched those lectures that you missed live, please answer the questions pertaining to the specific lecture. 66% or over per section need to be answered correctly to pass.
  • Once completed, simply press Submit
  • From receipt, processing and issuing your certificate will take 7-10 days. We will communicate with you should we have any queries.
  • Any questions, please call Jeremy Phillips, AAMP Educational Credit Coordinator at 954.540.1286
  • Deadline for submissions: December 31st, 2021
Name(Required)

Module 1
Dr. Paul Anderson

“Overview of Cardiovascular Pathophysiology and Pharmacology”

Left sided CHF is often due to chronic hypertension:
“Blood turbulence” triggers ________________
The drugs used for hypertension, angina, and dysrhythmia are:

Module 2
Dr. Steve Parcell

“Gender Differences in Cardiovascular Disease”

The presentation asserts: “Ischemic heart disease (IHD) is a term appropriate for this discussion because it is more specific to women, rather than CAD or CHD.”
Regarding women and MI:
The following was NOT asserted in this presentation regarding women and lipids:

Module 3
Dr. Kasra Pournadeali

“Updates on Non-Drug Options in Hypertension”

The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease stated: “The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.”
Known Risk Factors for HTN include:
A study cited asserted:

Dr. Kasra Pournadeali

“Updates on Non-Drug Options in Dysrhythmias”

The most common arrhythmia is:
Some risks mentioned for A-Fib are:
Three lifestyle measures mentioned for A-Fib:

Module 4
Dr. Steve Parcell

“Updates on Non-Drug options in Hyperlipidemia”

Regarding LDL size:
Regarding “Apo-B”:
Overall, niacin was presented as:

Dr. Kasra Pournadeali

“Updates on Non-Drug options in Heart Failure”

“Updates on Non-Drug options in Heart Failure”
Supplements mentioned are:
Diet intervention mentioned was:
This field is for validation purposes and should be left unchanged.